BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7300801)

  • 1. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.
    Aronsson B; Möllby R; Nord CE
    Med Microbiol Immunol; 1981; 170(1):27-35. PubMed ID: 7300801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.
    Aronsson B; Möllby R; Nord CE
    J Infect Dis; 1985 Mar; 151(3):476-81. PubMed ID: 3973405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile and antibiotic associated diarrhoea in Sweden.
    Aronsson B; Möllby R; Nord CE
    Scand J Infect Dis Suppl; 1982; 35():53-8. PubMed ID: 6962998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.
    Pituch H; van den Braak N; van Leeuwen W; van Belkum A; Martirosian G; Obuch-Woszczatyński P; Łuczak M; Meisel-Mikołajczyk F
    Clin Microbiol Infect; 2001 Aug; 7(8):442-6. PubMed ID: 11591209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
    Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.
    George WL; Rolfe RD; Finegold SM
    J Clin Microbiol; 1982 Jun; 15(6):1049-53. PubMed ID: 7107838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis.
    Ryan RW
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):79S-86S. PubMed ID: 3516548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal flora of patients with suspected antibiotic associated diarrhea (AAD). I. Clostridium perfringens].
    Pituch H; Martirosian G; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2000; 52(4):375-82. PubMed ID: 11286179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
    Kobayashi T
    Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children.
    Gogate A; De A; Nanivadekar R; Mathur M; Saraswathi K; Jog A; Kulkarni MV
    Indian J Med Res; 2005 Dec; 122(6):518-24. PubMed ID: 16518003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and significance of Clostridium difficile in faecal specimens of hospitalized children.
    Karsch W; Strelau E; Grahlow WD; Fischer E; Schulz R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):441-8. PubMed ID: 2494813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea.
    Ackermann G; Thomalla S; Ackermann F; Schaumann R; Rodloff AC; Ruf BR
    J Med Microbiol; 2005 Feb; 54(Pt 2):149-153. PubMed ID: 15673508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.
    Dzink J; Bartlett JG
    Antimicrob Agents Chemother; 1980 Apr; 17(4):695-8. PubMed ID: 7396460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects.
    Möllby R; Nord CE; Aronsson B
    Scand J Infect Dis Suppl; 1980; (Suppl 22):30-6. PubMed ID: 6937945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between production of toxins A and B and types of Clostridium difficile.
    Wren B; Heard SR; Tabaqchali S
    J Clin Pathol; 1987 Dec; 40(12):1397-401. PubMed ID: 3123524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clostridium difficile and its cytotoxin in the stools of young hospitalized children. Influence of antibiotic treatment].
    Collignon A; Cotte-Laffitte J; Quero AM; Torlotin JC
    Pathol Biol (Paris); 1986 Nov; 34(9):977-82. PubMed ID: 3543815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.